[Mortality among hospitalized patients did not appear to increase during the summer].

Mortalitet bland sjukhusvårdade tycktes inte öka under sommaren - Analys från Universitetssjukhuset i Linköping.

Journal

Lakartidningen
ISSN: 1652-7518
Titre abrégé: Lakartidningen
Pays: Sweden
ID NLM: 0027707

Informations de publication

Date de publication:
11 Jun 2019
Historique:
entrez: 14 6 2019
pubmed: 14 6 2019
medline: 19 9 2019
Statut: epublish

Résumé

A retrospective review of medical records (2017-2018) at Linköping University Hospital compared hospital mortality for the 2-month period of summer vacations (group A) with two months of regular activity (group B). The mortality was 163 patients in group A and 216 in group B. Emergency admittance dominated (95%) in both groups. Comorbidity was found in 81%, and at admittance the risk for death during the hospital stay was estimated to more than 50% in three out of four patients. There was no difference between the groups regarding demography, hospital stay, or diagnosis. Due to a 30% reduction of hospital beds during the summer some patients were relocated to other specialties. No relocated patient died in group A but six in group B. Eight deaths were judged as probably preventable, but none definitely preventable. The similarity between the groups regarding mortality does not allow estimations of differences in adverse events in general. Low mortality among relocated patients is probably due to identification of high-risk patients not suitable for relocation.

Identifiants

pubmed: 31192377
pii: FMX6
pii:

Types de publication

Journal Article

Langues

swe

Sous-ensembles de citation

IM

Auteurs

Christer Andersson (C)

Universitetssjukhuset i Linkoping - Chefsläkarenheten Linkoping, Sweden Universitetssjukhuset i Linkoping - Chefsläkarenheten Linkoping, Sweden.

Martin Magnusson (M)

Region Östergötland - Ledningsstaben, Linköping, Sweden.

Rune Sjödahl (R)

Universitetssjukhuset i Linköping, Kirurgiska kliniken, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH